Exact Sciences schedules fourth quarter 2020 earnings call
Exact Sciences Corp. (Nasdaq: EXAS) is set to release its fourth quarter 2020 financial results on February 16, 2021, after U.S. market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Exact Sciences Corp. (Nasdaq: EXAS) is set to release its fourth quarter 2020 financial results on February 16, 2021, after U.S. market close. Management will host a webcast and conference call at 5 p.m. EST to discuss the financial results and business progress. The company is a leading provider of cancer screening and diagnostic tests, with an emphasis on improving patient care through products like Cologuard and Oncotype DX. For further details, visit their official website.
Positive
- Scheduled release of fourth quarter 2020 financial results indicating transparency.
- Management intends to discuss business progress, suggesting ongoing developments.
Negative
- None.
Details
News Market Reaction – EXAS
The recorded move for EXAS in the trading session of this news was +0.90%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MADISON, Wis., Feb. 1, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company plans to release its fourth quarter 2020 financial results after the close of the U.S. financial markets on February 16, 2021. Following the release, company management will host a webcast and conference call at 5 p.m. EST to discuss financial results and business progress.
Fourth quarter 2020 webcast & conference call details
Date: | Tuesday, February 16, 2021 |
Time: | 5 p.m. EST, 4 p.m. CST |
Webcast: | The live webcast can be accessed at www.exactsciences.com |
Telephone: | Domestic callers, dial 833-235-7650 |
International callers, dial +1 647-689-4171 | |
Access code for both domestic and international callers: 2892148 |
An archive of the webcast will be available at www.exactsciences.com. A replay of the conference call will be available by calling 800-585-8367 domestically or 416-621-4642 internationally. The access code for the replay of the call is 2892148. The webcast, conference call and replay are open to all interested parties.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard and Oncotype DX, Exact Sciences is investing in its product pipeline to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook.
Contact:
Megan Jones
Exact Sciences Corp.
meganjones@exactsciences.com
608-535-8815
View original content to download multimedia:http://www.prnewswire.com/news-releases/exact-sciences-schedules-fourth-quarter-2020-earnings-call-301218577.html
SOURCE EXACT SCIENCES CORP
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.